ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043q107 Class: COM

ROSENBLUM SILVERMAN SUTTON S F INC /CA's Holding History (CIK: 0000918893)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 34,632 Value ($000) $9,351 Avg Close Range
Q4 2024
Shares 34,775 Value ($000) $8,183 Avg Close Range
Q3 2024
Shares 35,155 Value ($000) $9,669 Avg Close Range
Q2 2024
Shares 35,200 Value ($000) $8,554 Avg Close Range
Q1 2024
Shares 35,470 Value ($000) $5,301 Avg Close Range
Q4 2023
Shares 35,937 Value ($000) $6,879 Avg Close Range
Q3 2023
Shares 37,053 Value ($000) $6,562 Avg Close Range
Q2 2023
Shares 37,153 Value ($000) $7,057 Avg Close Range
Q1 2023
Shares 37,543 Value ($000) $7,521 Avg Close Range
Q4 2022
Shares 39,883 Value ($000) $9 Avg Close Range
Q3 2022
Shares 40,129 Value ($000) $8,032 Avg Close Range
Q2 2022
Shares 42,606 Value ($000) $6,214 Avg Close Range
Q1 2022
Shares 41,761 Value ($000) $6,819 Avg Close Range
Q4 2021
Shares 42,359 Value ($000) $7,183 Avg Close Range
Q3 2021
Shares 43,024 Value ($000) $8,123 Avg Close Range
Q2 2021
Shares 43,441 Value ($000) $7,364 Avg Close Range
Q1 2021
Shares 42,895 Value ($000) $6,056 Avg Close Range
Q4 2020
Shares 42,090 Value ($000) $5,470 Avg Close Range
Q3 2020
Shares 41,855 Value ($000) $6,094 Avg Close Range
Q2 2020
Shares 38,995 Value ($000) $5,776 Avg Close Range
Q1 2020
Shares 37,670 Value ($000) $4,100 Avg Close Range